{
    "persona": "conservative",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "Dutch",
    "text": "70% van patiÃ«nten met #atogepant 60 mg dagelijks hadden minstens 50% reductie in maandelijkse migrainedagen na 13-16 weken en dit bleef bestaan over 48 weken behandeling.",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "efbcf83db94abd0e33dd3235f5c6adf2eaadf93bcd64675d"
}